New Qui Tam Worry: Lawsuits Over False Patent Markings

In the last two months, pharmaceutical companies have been hit with a wave of whistleblower suits claiming they intentionally included expired patents on their product labeling to deter competition

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet